Source: International Congress 2019 – Personalised medicine in COPD: Matching the patient needs with the right care
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Martinez (New York, United States of America). A personalised medicine approach to ICS use in COPD. International Congress 2019 – Personalised medicine in COPD: Matching the patient needs with the right care

Member's Comments

No comment yet.

Related content which might interest you: The future of personalised medicine in COPD Source: International Congress 2016 – Endotyping: the means to personalised medicine in lung disease Year: 2016 Evaluation of the use of e-learning in training management of asthma and COPD in general medicine. Source: International Congress 2017 – Medical education, web and internet Year: 2017 Biomarkers and personalised medicine for asthma Source: Eur Respir J, 53 (1) 1802094; 10.1183/13993003.02094-2018 Year: 2019 In the era of personalized medicine, what are the current unmet needs in asthma? Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now? Year: 2019 Triple therapy trials in COPD: a precision medicine opportunity Source: Eur Respir J, 52 (6) 1801848; 10.1183/13993003.01848-2018 Year: 2018 Developing evidence-based recommendations regarding inhalation technique in patients with COPD Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020 From guidelines to personalized treatment of children with asthma Source: Virtual Congress 2020 – Which paediatric asthma guidelines are the most appropriate for children and adolescents? Year: 2020 The impact of personalised therapies on respiratory medicine Source: Eur Respir Rev 2013; 22: 72-74 Year: 2013 “To define is to limit”: perspectives on asthma–COPD overlap syndrome and personalised medicine Source: Eur Respir J, 49 (5) 1700336; 10.1183/13993003.00336-2017 Year: 2017 A NMR-based metabolomics approach to the assessment of inhaled pharmacotherapy in patients with COPD Source: International Congress 2019 – Basic research of airway diseases Year: 2019 COPD guides and inhaled corticosteroids. Is there an adequate use in primary care? Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care Year: 2016 Is there a need for pharmacoepidemiology in asthma and COPD? Source: Annual Congress 2004 - Pharmacoepidemiology of obstructive lung disease: beyond clinical trials Year: 2004 Personalised medicine in exacerbations of COPD: the beginnings Source: Eur Respir J 2012; 40: 1318-1319 Year: 2012 Efficacy of comprehensive education program including inhaler training and disease management on COPD Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 Personalised medicine in asthma: from curative to preventive medicine Source: Eur Respir Rev 2017; 26: 160010 Year: 2017 Predictive and personalised medicine for asthma using genomics Source: Annual Congress 2012 - Genetics and genomics in asthma and COPD: prediction and personalised medicine Year: 2012 Linking phenotypes to personalised treatments in asthma and COPD Source: Virtual Congress 2021 – Precision medicine in asthma and COPD Year: 2021 Validation of a new inhaled therapeutic algorithm for the stable COPD patient: The COPD easy treatment project Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care Year: 2015